Antibiotic resistance is a worry for human and plant health alike. The more we use existing antibiotics in clinical settings and in agriculture, the more antibiotic resistance develops. Without new antibiotic compounds, we will struggle to treat once-controlled diseases in both humans and plants.
Exciting new research from Europe details the discovery of a new antifungal antibiotic called solanimycin hiding within a bacteria which causes disease in potatoes.
Most therapeutic antibiotics actually come from soil microbes, so this discovery broadens the search for new compounds to plant-based microorganisms.
“We have to look more expansively across much more of the microbial populations available to us,” said Dr. Rita Monson a microbiologist at the University of Cambridge and one of the study’s authors.
The bacteria itself, known as Dickeya solani, has been known for over 15 years, with another antibiotic called oocydin A originally isolated from the bacteria and used as an effective fungicide against many plant ailments.
From this, and a sequencing of the bacterium’s genome, the researchers realised the potential for other antibiotic compounds to be hiding in the background. When they switched off the genes responsible for producing oocydin A and when the bacteria were within an acidic background – such as that found inside a potato – it would switch on genes responsible for creating solanimycin.
“It’s an antifungal that we believe that will work by killing fungal competitors, and the bacteria benefit so much from this,” said Monson. “But you don’t turn it on unless you’re in a potato.”
Solanimycin has been demonstrated to act against fungal disease in both plants and also on a common organism known as Candida albicans, which is present inside the body naturally, but can become out of control and cause dangerous infections.
Monson and colleagues want to understand more about solanimycin and how it works, so they have teamed up with chemists to investigate the molecular structure in detail. From there, they hope to progress to testing the compound in plant and animal models.
Clare Kenyon is a science journalist for Cosmos. An ex-high school teacher, she is currently wrangling the death throes of her PhD in astrophysics, has a Masters in astronomy and another in education. Clare also has diplomas in music and criminology and a graduate certificate of leadership and learning.
Read science facts, not fiction...
There’s never been a more important time to explain the facts, cherish evidence-based knowledge and to showcase the latest scientific, technological and engineering breakthroughs. Cosmos is published by The Royal Institution of Australia, a charity dedicated to connecting people with the world of science. Financial contributions, however big or small, help us provide access to trusted science information at a time when the world needs it most. Please support us by making a donation or purchasing a subscription today.